Neurogen (NRGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurogen (NRGN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (197)	2/2/1999 3:26:00 PM
From: JFitnich	Read Replies (1) of 523

Guess the thread is pretty quiet when news like this hasn't been talked about. I was interested in this program (91-2) 1)Because of Pfizer's involvement and 2) I think the anxiety market is underserved and ready to explode. Buspar is not a great drug, IMHO, and I think somebody else could come in and clean up so to speak. IPIC's Pagaclone program is looking very interesting to me. Here's the release. biz.yahoo.com This to me seems like a great time to buy NRGN. They've got a lot of irons in the fire and poor results aside, seem like a 1st rate organization. Any thoughts or criticisms?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next